logo
Looking back to the strength of a people's movement against filariasis

Looking back to the strength of a people's movement against filariasis

The Hindu22-04-2025

The World Health Organization has sought to eliminate filariasis, globally, by 2030, a decade later than its original target of 2020. While India's target year is now 2027, this deadline has been arrived at after several revisions: the National Health Policy had originally set the goalpost for 2015. Filariasis, clearly, has been difficult disease to eradicate.
While pioneering experiments by vector specialists over the years have helped India reduce its disease burden, consistent efforts are needed to eliminate the disease, reports have acknowledged.
'Filariasis is the common term for a group of diseases caused by parasitic nematodes belonging to the superfamily Filarioidea. Adult worms of these parasites live in the lymphatic system, cutaneous tissues or body cavity of the humans and are transmitted through vectors', explains a documents from the National Centre for Vector Borne Diseases Control.
Filariasis caused by nematodes that live in the human lymph system is called Lymphatic Filariasis (LF). The burden of lymphatic filariasis is massive in India, with as many as 670 million persons at risk for the disease, according to a report published in the Indian Journal of Medical Research in 2022.
While the disease has been around for decades in India, there still exist many misconceptions about it, says S. Sabesan, former director of the Indian Council of Medical Research -- Vector Control Research Centre, Puducherry.
Kerala's story with filariasis
Kerala was instrumental in spotlighting filariasis in India. In 1984-85, a group of filariasis affected persons in Alappuzha formed an association, and its president contested the general election that year, aiming to attract the attention of politicians and bureaucrats. It bore fruit. A Member of Parliament from Kerala S. Krishna Kumar, became the deputy minister in the Union Health Ministry. He called for action against filariasis in Kerala, which set the ball rolling, recalls Dr. Sabesan.
Kerala's culture of associations helped to further the project of eliminating filariasis, he says. All associations were amassed under the umbrella of the Filariasis control movement or 'Filco' movement. The project targeted removing floating vegetation where mosquitoes that cause the disease breed. The mosquitoes lay eggs on leaves and the larvae absorb oxygen from the air sacs in the roots of the plants. Understanding the breeding pattern of the mosquitoes helped remove the floating vegetation, which was then placed as manure in coconut groves.
To control mosquitoes the State Health Department also targeted Kerala's large resource of ponds and water bodies to develop aquaculture, using fish from dams. The fish would feed on the larvae, curtailing mosquito breeding.
Interdepartmental support
Support also came from Kerala's Agriculture Department which saw the potential of improving livelihoods in rural areas. Shramdhan workers cleaned temple tanks, canals and water bodies, and NABARD pitched in with financial support to remove the plants, and establish aquaculture.
In two years, inland fisheries had been developed. To add value to the removed water vegetation, hemp was cultivated. This improved the quality of fertilisers that coconut groves received. Ultimately, the Health Department roped in the Education Department to raise an army of schoolchildren who could spread awareness to help improve adherence to treatment of the disease.
The Health Department also used the knowledge of how village residents checked the feet of eligible young women to check if they harboured the disease before offering a marriage proposal. The Department made a young woman with lymphatic oedema, in whose family many women had been rejected owing to the disease, their mascot. The young woman recovered from filariasis after treatment and this boosted people's confidence. Her story was made into a short film, Yudham (war) and exhibited, giving further fillip to treating the disease. Alongside, the Department trained Filco workers to detect the disease and bring in patients for treatment.
Free clinics were opened to offer treatment. The next step was checking for hidden disease, which involved mass drug administration. Soon, the number of cases fell drastically indicating that the disease was in the elimination stage.
A win, and a mass strategy
The success of the experiment was shared at the WHO's meeting in 1996 in Kuala Lampur and the World Health Assembly decided on a strategy of administering a single dose of diethylcarbamazine citrate (DEC).
In India, the annual single dose mass therapy was introduced in 2002, but the nation-wide the scheme did not help in eliminating the disease, for want of follow-up care.
In 2006, the Union Health Ministry introduced the drug Albandazole that can have an effect on adult worms of the parasite. But there was a lack of compliance, even though the drugs were distributed. The Health Ministry found that despite distributing the drug there, was no reduction in the number of cases.
Meanwhile in Kerala another development took place.
The salt story
Through a project, salt-infused with a low dose of the drug DEC was introduced in Kerala. This project was launched with the support of the salt corporation in Thoothukudi in Tamil Nadu. Within a year, the number of filariasis cases fell significantly. The project's success was expanded in Tamil Nadu's Kanyakumari district in 2003.
By 2020, the Indian Council of Medical Research launched DEC salt in Andaman and Nicobar and successfully eliminated another variety of filariasis. This salt therapy could be used as an adjunct therapy across the country Dr. Sabesan has said in the white paper he has published on the subject: Not only is it odourless, but it also doesn't change the colour of food and is safe for pregnant women and children as well.
For the success to be sustained it is imperative that we achieve the target of elimination, he says. 'Tamil Nadu is doing well. But filariasis is found in Karnataka, Andhra Pradesh, Bihar and Uttar Pradesh as well. There are areas where filariasis is a challenge. If uncontrolled, filariasis will be reintroduced, as the vector is already present in the atmosphere. The low density carriers will build up gradually. So it is necessary to continue surveillance even after elimination is declared. Vector entomologists must focus on the mosquitoes and the vector,' he emphasises.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gaza's Al-Amal Hospital "Virtually Out Of Service": WHO
Gaza's Al-Amal Hospital "Virtually Out Of Service": WHO

NDTV

time4 hours ago

  • NDTV

Gaza's Al-Amal Hospital "Virtually Out Of Service": WHO

Gaza City: The Al-Amal Hospital in Gaza, one of the few still operating in the Palestinian territory, is now "virtually out of service" due to intense military activity, the head of the WHO said Monday. "Access to the hospital is obstructed, preventing new patients from reaching care, and leading to more preventable deaths," the World Health Organization's director-general Tedros Adhanom Ghebreyesus posted on X. Tedros said two emergency medical teams - one local, the other international - "are still doing their best to serve the remaining patients with the limited medical supplies left on the premises." "With the closure of Al-Amal, Nasser Medical Complex is now the only remaining hospital with an intensive care unit in Khan Younis," he said. The WHO said June 5 that al-Nasser and Al-Amal hospitals were unable to fully treat the wounded that continue to pour in because of serious shortages of medicines and medical supplies after two months of total blockade. Israeli authorities have recently allowed in some humanitarian aid, but way less than what is needed. Nearly 20 months of relentless war, triggered by Hamas' October 7, 2023 attacks on Israel, has created one of the most serious humanitarian crises in the world, with civilians exhausted by bombardments, forced displacement and hunger.

Mamata Banerjee reviews Covid preparedness in Bengal, says 'no reason to panic'
Mamata Banerjee reviews Covid preparedness in Bengal, says 'no reason to panic'

India Today

time7 hours ago

  • India Today

Mamata Banerjee reviews Covid preparedness in Bengal, says 'no reason to panic'

West Bengal Chief Minister Mamata Banerjee on Sunday reviewed Covid-19 preparedness in the state amid rising cases. She assured the public that there is no cause for panic at this Chief Minister chaired a high-level meeting at the state secretariat with key officials from all major departments to assess the current situation and prepare for any potential escalation."Nothing to panic at present for Covid. Just need to be cautious and aware," Banerjee said after the meeting. "We have prepared ourselves, and we're hopeful it won't lead to a pandemic. Still, we must remain alert and ready."advertisement She advised Covid-19 patients to seek treatment in government hospitals to avoid high medical expenses, and reiterated that the government has taken all necessary steps to stay prepared in case the situation worsens."As of now, the situation is not worrisome. We've had a detailed meeting with every department, and according to the official information we have, the condition is under control," she that the World Health Organization (WHO) has not declared the current outbreak a pandemic, she said, "It's a kind of virus similar to influenza. People with comorbidities should be especially cautious."As of June 9, West Bengal has reported 747 active Covid-19 cases, with 54 new infections added in the past 24 hours, according to the latest state Ministry of Health and Family Welfare has reported 6,491 active cases in India, with Kerala continuing to be the worst-affected state, recording 1,957 active the recent surge, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) has identified over 160 cases linked to the new XFG InMust Watch

Measles cases surging globally. Should children be vaccinated earlier?
Measles cases surging globally. Should children be vaccinated earlier?

Time of India

time12 hours ago

  • Time of India

Measles cases surging globally. Should children be vaccinated earlier?

Sydney: Measles has been rising globally in recent years. There were an estimated 10.3 million cases worldwide in 2023, a 20 per cent increase from 2022. Outbreaks are being reported all over the world including in the United States, Europe and the Western Pacific region (which includes Australia ). For example, Vietnam has reportedly seen thousands of cases in 2024 and 2025. In Australia, 77 cases of measles have been recorded in the first five months of 2025, compared with 57 cases in all of 2024. Measles cases in Australia are almost all related to international travel. They occur in travellers returning from overseas, or are contracted locally after mixing with an infected traveller or their contacts. Measles most commonly affects children and is preventable with vaccination, given in Australia in two doses at 12 and 18 months old. But in light of current outbreaks globally, is there a case for reviewing the timing of measles vaccinations? Some measles basics Measles is caused by a virus belonging to the genus Morbillivirus. Symptoms include a fever, cough, runny nose and a rash. While it presents as a mild illness in most cases, measles can lead to severe disease requiring hospitalisation, and even death. Large outbreaks can overwhelm health systems. Measles can have serious health consequences, such as in the brain and the immune system, years after the infection. Measles spreads from person to person via small respiratory droplets that can remain suspended in the air for two hours. It's highly contagious - one person with measles can spread the infection to 12-18 people who aren't immune. Because measles is so infectious, the World Health Organization (WHO) recommends two-dose vaccination coverage above 95 per cent to stop the spread and achieve "herd immunity". Low and declining vaccine coverage, especially since the COVID pandemic, is driving global outbreaks. When are children vaccinated against measles? Newborn babies are generally protected against measles thanks to maternal antibodies. Maternal antibodies get passed from the mother to the baby via the placenta and in breast milk, and provide protection against infections including measles. The WHO advises everyone should receive two doses of measles vaccination. In places where there's a lot of measles circulating, children are generally recommended to have the first dose at around nine months old. This is because it's expected maternal antibodies would have declined significantly in most infants by that age, leaving them vulnerable to infection. If maternal measles antibodies are still present, the vaccine is less likely to produce an immune response. Research has also shown a measles vaccine given at less than 8.5 months of age can result in an antibody response which declines more quickly. This might be due to interference with maternal antibodies, but researchers are still trying to understand the reasons for this. A second dose of the vaccine is usually given 6-9 months later. A second dose is important because about 10-15 per cent of children don't develop antibodies after the first vaccine. In settings where measles transmission is under better control, a first dose is recommended at 12 months of age. Vaccination at 12 months compared with nine months is considered to generate a stronger, longer-lasting immune response. In Australia, children are routinely given the measles-mumps- rubella ( MMR ) vaccine at 12 months and the measles-mumps-rubella-varicella (MMRV, with "varicella" being chickenpox) vaccine at 18 months. Babies at higher risk of catching the disease can also be given an additional early dose. In Australia, this is recommended for infants as young as six months when there's an outbreak or if they're travelling overseas to a high-risk setting. A new study looking at measles antibodies in babies A recent review looked at measles antibody data from babies under nine months old living in low- and middle-income countries. The review combined the results from 20 studies, including more than 8,000 babies. The researchers found that while 81 per cent of newborns had maternal antibodies to measles, only 30 per cent of babies aged four months had maternal antibodies. This study suggests maternal antibodies to measles decline much earlier than previously thought. It raises the question of whether the first dose of measles vaccine is given too late to maximise infants' protection, especially when there's a lot of measles around. Should we bring the measles vaccine forward in Australia? All of the data in this study comes from low- and middle-income countries, and might not reflect the situation in Australia where we have much higher vaccine coverage for measles, and very few cases. Australia's coverage for two doses of the MMR vaccine at age two is above 92 per cent. Although this is lower than the optimal 95 per cent, the overall risk of measles surging in Australia is relatively low. Nonetheless, there may be a case for broadening the age at which an early extra dose of the measles vaccine can be given to children at higher risk. In New Zealand, infants as young as four months can receive a measles vaccine before travelling to an endemic country. But the current routine immunisation schedule in Australia is unlikely to change. Adding an extra dose to the schedule would be costly and logistically difficult. Lowering the age for the first dose may have some advantages in certain settings, and doesn't pose any safety concerns, but further evidence would be required to support this change. In particular, research is needed to ensure it wouldn't negatively affect the longer-term protection that vaccination offers from measles. Making sure you're protected In the meantime, ensuring high levels of measles vaccine coverage with two doses is a global priority. People born after 1966 are recommended to have two doses of measles vaccine. This is because those born before the mid-1960s likely caught measles as children (when the vaccine was not yet available) and would therefore have natural immunity. If you're unsure about your vaccination status, you can check this through the Australian Immunisation Register . If you don't have a documented record, ask your doctor for advice. Catch-up vaccination is available under the National Immunisation Programme . (The Conversation) PY PY

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store